Condition

Cardiotoxicity (2)

HER2/Neu Positive (1)

Lung Cancer Stage II (1)

Lung Cancer Stage III (1)

Metastatic Malignant Neoplasm in the Brain (1)

Radiation Toxicity (1)

Recurrent Breast Carcinoma (1)

Stage IV Breast Cancer AJCC v6 and v7 (1)

Overall Status

Enrolling by invitation (1)

Recruiting (1)

Phase

phase 3 (1)

Sponsor

Abramson Cancer Center of the University of Pennsylvania (1)

Southwest Oncology Group (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

carvedilol (1)

chemoradiation (1)

laboratory biomarker analysis (1)

patient observation (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

cardiotoxicity

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated

Enrolling by invitation

Cardiotoxicity
+3 more

Chemoradiation

Birmingham, Alabama
+6 more

Nov 1, 2022

Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Tumor in the Brain Trial in Worldwide (Carvedilol, Laboratory Biomarker

Recruiting

Cardiotoxicity
+4 more

Carvedilol
+2 more

Anchorage, Alaska
+579 more

Nov 8, 2021